Severe COVID-19 cases exhibit aberrant immune responses, compromised innate-adaptive crosstalk, and alterations in peripheral blood cell composition, including elevated CD14+ and CD16+ monocytes and reduced overall B cells (31, 32). The gene discussed is CD14; the disease is COVID-19.